-
Recent Posts
- Gevo, Inc. (NASDAQ: GEVO) Gets Big Boost Following Resumption of Isobutanol Production
- Will Generex Biotechnology Corp. (OTCQB: GNBT) Advance Breast Cancer Treatment to the Next Stage?
- Amicus Therapeutics, Inc. (NASDAQ: FOLD) Taking a Hit Following FDA Decision
- Titan Energy Worldwide, Inc. (OTCQB: TEWI) Generating Strong Revenue but can they become Profitable?
- Belo Corp. (NYSE: BLC) Soaring Following Announced Deal with Gannett Co., Inc. (NYSE: GCI)
Categories
OTC Equity Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods china copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare healthcare stocks investors ipad iphone medical marijuana mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks pharmaceutical Pink Sheets pinksheets s silver sprint stocksSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: oral-lyn
Will Generex Biotechnology, Inc. (OTCBB: GNBT) Ever See Potential Translate into Revenue Generating Product Development?
Shareholders of Generex Biotechnology, Inc. (OTCBB: GNBT) have been banking on the company’s potential for some time, often relying on that potential to carry them through some disappointing setbacks and financial uncertainty, but how much longer can investors gamble on … Continue reading
Posted in Articles, OTC Bulletin Board, Penny Stocks
Tagged amarantus, ambs, breast cancer, cancer, diabetes, drug, generex biotechnology, gnbt, investors, oral-lyn, otcbb, penny stocks, rapidmist
Leave a comment
Debate Over Reverse Stock Split, Questions Concerning Product Development Continue to Plague Generex Biotechnology Corporation
With the debate over the proposed reverse stock split still raging and their Phase III trial of Oral-lyn now several months behind schedule the future of Generex Biotechnology Corporation (OTCBB: GNBT) appears to be up in the air. While the … Continue reading


